Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of COVID-19 Vaccines Against Coronavirus Disease (COVID-19) Among Tuberculosis (TB) Patients in Thailand-Myanmar Border.

NCT05571735 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT05571735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05571735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of COVID-19 Vaccines Against Coronavirus Disease (COVID-19) Among Tuberculosis (TB) Patients in Thailand-Myanmar Border.
Lead sponsor
University of Oxford
Phase
Observational
Overall status
Recruiting
Start date
April 15, 2023
Completion date
June 30, 2026
Enrollment
133 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pandemics, tuberculosis